Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
04/2012
04/25/2012CN101475577B 氯吡格雷硫酸复盐化合物及其制备方法 Clopidogrel sulfate double salt compounds and methods
04/25/2012CN101066973B 稳定噻吩衍生物的方法 Stable thiophene derivatives
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163479 Specific substrates for O6-alkylguanine-DNA alkyltransferase
04/19/2012WO2012051318A1 Sulphonamide compounds and methods of making and using same
04/19/2012WO2012050500A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/19/2012WO2012050159A1 Amide derivative and use thereof
04/19/2012WO2012050103A1 Condensed aromatic compound, organic semiconductor material, and organic transistor element
04/19/2012WO2012050001A1 Chalcogen-containing aromatic compound, organic semiconductor material, and organic electronic device
04/19/2012WO2012048531A1 Dibenzo compound and derivative of same, and preparation method and use therefor
04/19/2012WO2011149288A3 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same
04/19/2012US20120095234 Processes and intermediates for preparing fused heterocyclic kinase inhibitors
04/19/2012US20120095035 Crystals of prasugrel hydrobromate
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012CA2814688A1 Heteroaryls and uses thereof
04/19/2012CA2814413A1 Sulphonamide compounds and methods of making and using same
04/19/2012CA2813711A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/18/2012EP2442107A2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use
04/18/2012EP2441768A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers
04/18/2012EP2121691B1 Spirocyclic cyclohexane derivatives
04/18/2012CN102421783A Herbicidal compounds
04/18/2012CN102421760A Dihydropyrimidinones for use as bace2 inhibitors
04/18/2012CN102417514A 吡啶衍生物、其制备方法和用途 Pyridine derivatives, their preparation and use
04/17/2012US8158825 Modified malonate derivatives
04/17/2012CA2570415C An improved process for the preparation of 5,6 -dihydro -4h-4(s)-ethylamino-6(s)-methylthieno[2,3-b] thiopyran-2-sulfonamide- 7,7 -dioxide and its salt
04/17/2012CA2450007C Compounds and methods for the treatment or prevention of flavivirus infections
04/12/2012WO2012046818A1 Method for producing chalcogen-containing condensed polycyclic compound
04/12/2012WO2012006603A3 Clickable cross-linker
04/12/2012US20120088921 Compound, organic semiconductor material, and semiconductor device
04/12/2012US20120088770 Alpha helix mimetics and methods relating thereto
04/12/2012US20120088764 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088241 Bioreactive Agents
04/11/2012EP2438071A1 Substituted pyrazine (thio)pyrans with a herbicidal action
04/11/2012CN102414209A 运动障碍治疗剂 Dyskinesia therapeutic agent
04/11/2012CN102408433A 含嘧啶的肟类化合物、其制备方法和用途 Oxime-containing pyrimidine compounds, their preparation and use
04/10/2012US8153639 Substituted thieno- and furano- fused pyrimidines as PI3K inhibitors
04/10/2012US8153629 Pharmaceutical compounds
04/10/2012CA2634646C Pyrimidine derivatives for the treatment of abnormal cell growth
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/05/2012WO2012044993A1 Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
04/05/2012WO2012042265A1 Novel acridine derivatives
04/05/2012WO2012040845A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
04/05/2012US20120083599 Biomolecular Labelling Using Multifunctional Biotin Analogues
04/05/2012US20120080670 Compound containing a 5-membered heterocycle and organic light-emitting diode using same, and terminal for same
04/05/2012CA2811465A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
04/04/2012EP2435440A1 New spiroheterocyclic furan and thiofuran dione derivatives
04/04/2012EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions
04/04/2012CN102399233A PI3K和mTOR双重抑制剂类化合物 PI3K and mTOR dual inhibitor compounds
04/04/2012CN102399232A 普拉格雷的氘代酸加成盐 Prasugrel deuterated acid addition salt
04/04/2012CN101701020B 一类酰胺衍生物、其制备方法和用途 A class of amide derivatives, their preparation and use
04/03/2012US8148548 Heterocyclic fused selenophene monomers
04/03/2012US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
04/03/2012US8148400 Thiazolyl compounds useful as kinase inhibitors
04/03/2012US8148384 8-bromo-2-[(3-hydroxyphenylamino)methyl]-3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-one; ischemia reperfusion injury, inflammatory disease, retroviral infections, ischemia reperfusion injury, myocardial infarction
04/03/2012US8148062 Detection of disease related genes
03/2012
03/29/2012WO2012039561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/29/2012WO2012038905A1 Thienopyridine nicotinamide derivatives, preparation thereof and therapeutic use thereof
03/29/2012WO2012038521A1 Novel microbiocides
03/29/2012WO2011144873A3 Organic compounds derived from 3,4-ethylenedioxythiophene, preparation method thereof and uses of same in electronics
03/29/2012US20120077980 Method for producing a solid preparation
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077814 Sulfonamide, sulfamate, and sulfamothioate derivatives
03/29/2012US20120077778 Ladder-Frame Polyether Conjugates
03/29/2012US20120074396 Electroactive materials
03/29/2012US20120074393 Semiconductors based on diketopyrrolopyrroles
03/28/2012EP2433943A1 Thienopyrazole derivatives having PDE7 inhibitory activity
03/28/2012EP2433942A1 Method for preparing d-biotin
03/28/2012EP2433938A1 Therapeutic agent for motor disorders
03/28/2012EP2432783A1 Modulators of 5-ht receptors and methods of use thereof
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP1598877B1 Switching element
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102391286A Synthetic process of tetrazolo[1,5-a]thiapyrano[3,4-d]pyrimidine derivative
03/28/2012CN102391285A Synthetic process of benzo[f]thieno[3,2-b]quinoline derivatives
03/28/2012CN102391284A Chiral poly (3,4-ethylenedioxythiophene) derivative monomer, polymer and preparation method thereof
03/28/2012CN102391283A Clopidogrel hydrogen sulfate compound and preparation method thereof
03/28/2012CN101838274B Improved preparation method of d-biotin
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012037141A1 Inhibitors of notum pectinacetylesterase and methods of their use
03/22/2012WO2012036293A1 Diabetes therapeutic agent
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012035934A1 Organic electroluminescent element
03/22/2012WO2012035853A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device
03/22/2012WO2012035078A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071319 Spiroheterocyclic furan and thiofuran dione derivatives
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2811080A1 Heterocyclic compound
03/22/2012CA2811005A1 Inhibitors of notum pectinacetylesterase and methods of their use
03/21/2012EP2431371A1 Thiophene derivatives
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2430029A1 Thieno [2, 3-b]pyridine derivatives as viral replication inhibitors
03/21/2012EP2430028A1 Herbicidal compounds
03/21/2012EP2430019A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
03/21/2012EP2430014A1 Antiviral compounds
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 214